Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

0.000p
   
  • Closing Price Chg:
    -45.00p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 0
  • RiskGrade: 128

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Genus Market Data

Currency UK Pounds
Share Price 2,465.00p
Closing Price Change -45.00p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 66.54m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page